Literature DB >> 1654219

Inhibitory effects of non-steroidal anti-inflammatory drugs on superoxide generation.

Y Yuda1, J Tanaka, K Suzuki, K Igarashi, T Satoh.   

Abstract

Effects of non-steroidal anti-inflammatory drugs (NSAID: amfenac sodium, diclofenac sodium, indomethacin and ketoprofen) on the generation of superoxide anion (O2-) by isolated rat polymorphonuclear leukocytes (PMN) were studied spectrophotometrically using cytochrome c. The effects of these drugs were also studied on O2- production by the xanthine-xanthine oxidase and reduced nicotinamide adenine dinucleotide phosphate (NADPH)-NADPH oxidase systems. Amfenac sodium, at 0.1 mM, inhibited significantly O2- generation in rat PMN induced by opsonized zymosan. At 0.5 mM, diclofenac sodium and indomethacin inhibited the O2- generation in rat PMN. All of the above drugs slightly inhibited O2- production by the xanthine-xanthine oxidase system. On the other hand, O2- production by the NADPH-NADPH oxidase system was significantly inhibited by the addition of amfenac sodium, ketoprofen or indomethacin. These results suggest that non-steroidal anti-inflammatory drugs do not work as an O2- scavenger and block O2- production by the NADPH-NADPH oxidase system of rat PMN. It is concluded that amfenac sodium and the other drugs are able to inhibit granulocyte O2- production by blocking the activation of NADPH-oxidase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654219     DOI: 10.1248/cpb.39.1075

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  2 in total

1.  Tetrahydrobiopterin impairs the action of endothelial nitric oxide via superoxide derived from platelets.

Authors:  M Tajima; H Sakagami
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

2.  Effects of ketoprofen on respiratory and circulatory changes in endotoxic shock.

Authors:  G H Sigurdsson; H A Youssef; A Banic
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.